AUD 0.02
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | - NZD | 0.0% |
2023 | - NZD | 0.0% |
2022 | - NZD | 0.0% |
2021 | - NZD | -100.0% |
2020 | 410.28 Thousand NZD | -34.51% |
2019 | 626.5 Thousand NZD | 0.0% |
2018 | - NZD | 0.0% |
2017 | - NZD | 0.0% |
2016 | - NZD | -100.0% |
2015 | 407.8 Thousand NZD | -46.51% |
2014 | 762.45 Thousand NZD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 FY | - NZD | 0.0% |
2024 Q4 | - NZD | 0.0% |
2024 Q1 | - NZD | 0.0% |
2024 Q2 | - NZD | 0.0% |
2024 Q3 | - NZD | 0.0% |
2023 Q4 | - NZD | 0.0% |
2023 Q3 | - NZD | 0.0% |
2023 Q2 | - NZD | 0.0% |
2023 Q1 | - NZD | 0.0% |
2023 FY | - NZD | 0.0% |
2022 Q4 | - NZD | 0.0% |
2022 Q2 | - NZD | 0.0% |
2022 FY | - NZD | 0.0% |
2022 Q1 | - NZD | 0.0% |
2022 Q3 | - NZD | 0.0% |
2021 Q3 | - NZD | -100.0% |
2021 Q4 | - NZD | 0.0% |
2021 FY | - NZD | -100.0% |
2021 Q1 | 436.84 Thousand NZD | 6.47% |
2021 Q2 | 436.84 Thousand NZD | 0.0% |
2020 Q4 | 410.28 Thousand NZD | 0.0% |
2020 FY | 410.28 Thousand NZD | -34.51% |
2020 Q3 | 410.28 Thousand NZD | -34.51% |
2020 Q2 | 626.5 Thousand NZD | 0.0% |
2020 Q1 | 626.5 Thousand NZD | 0.0% |
2019 FY | 626.5 Thousand NZD | 0.0% |
2019 Q4 | 626.5 Thousand NZD | 0.0% |
2019 Q3 | 626.5 Thousand NZD | 0.0% |
2019 Q1 | - NZD | 0.0% |
2019 Q2 | - NZD | 0.0% |
2018 Q1 | - NZD | 0.0% |
2018 FY | - NZD | 0.0% |
2018 Q4 | - NZD | 0.0% |
2018 Q3 | - NZD | 0.0% |
2018 Q2 | - NZD | 0.0% |
2017 Q1 | - NZD | 0.0% |
2017 Q4 | - NZD | 0.0% |
2017 FY | - NZD | 0.0% |
2017 Q2 | - NZD | 0.0% |
2017 Q3 | - NZD | 0.0% |
2016 Q2 | - NZD | 0.0% |
2016 FY | - NZD | -100.0% |
2016 Q4 | - NZD | 0.0% |
2016 Q3 | - NZD | 0.0% |
2016 Q1 | - NZD | -100.0% |
2015 Q3 | 407.8 Thousand NZD | 0.0% |
2015 Q1 | - NZD | 0.0% |
2015 FY | 407.8 Thousand NZD | -46.51% |
2015 Q2 | - NZD | 0.0% |
2015 Q4 | 407.8 Thousand NZD | 0.0% |
2014 FY | 762.45 Thousand NZD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
4DMedical Limited | 5.12 Million AUD | 100.0% |
Adherium Limited | 93.2 Thousand AUD | 100.0% |
Aroa Biosurgery Limited | 6.81 Million AUD | 100.0% |
Atomo Diagnostics Limited | 84.67 Thousand AUD | 100.0% |
Anteris Technologies Ltd | 2.33 Million AUD | 100.0% |
Control Bionics Limited | 961.73 Thousand AUD | 100.0% |
CardieX Limited | 3.22 Million AUD | 100.0% |
Compumedics Limited | 6.97 Million AUD | 100.0% |
Cochlear Limited | 243.7 Million AUD | 100.0% |
CleanSpace Holdings Limited | 3.44 Million AUD | 100.0% |
Cyclopharm Limited | 4.22 Million AUD | 100.0% |
EMVision Medical Devices Ltd | 2.9 Million AUD | 100.0% |
Nova Eye Medical Limited | 3.34 Million AUD | 100.0% |
HeraMED Limited | 260.65 Thousand AUD | 100.0% |
Imricor Medical Systems, Inc. | 15.7 Million AUD | 100.0% |
ImpediMed Limited | 1.14 Million AUD | 100.0% |
InhaleRx Limited | 560.27 Thousand AUD | 100.0% |
LBT Innovations Limited | 1.74 Million AUD | 100.0% |
Micro-X Limited | 4.05 Million AUD | 100.0% |
Neurotech International Limited | - AUD | NaN% |
OncoSil Medical Limited | 70.67 Thousand AUD | 100.0% |
PolyNovo Limited | 15.38 Million AUD | 100.0% |
Respiri Limited | 1.17 Million AUD | 100.0% |
SomnoMed Limited | 1.01 Million AUD | 100.0% |
Universal Biosensors, Inc. | 4.97 Million AUD | 100.0% |
Uscom Limited | 989.27 Thousand AUD | 100.0% |
Visioneering Technologies, Inc. | 312.15 Thousand AUD | 100.0% |